Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06020586
Other study ID # roffo
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 6, 2022
Est. completion date December 30, 2023

Study information

Verified date August 2023
Source Instituto de Oncología Ángel H. Roffo
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a Phase 2, single-center study designed to determine the effect of ECOHAIR topical solution on scalp hair growth evaluated objectively ( images) and subjectively ( patient and investigator reports). A total of 22 subjects are planned to be enrolled, 15 in a prospective single-arm phase in which they will receive the study treatment and 7 controls. Patients should have a clinical diagnosis of chemotherapy-induced alopecia.


Recruitment information / eligibility

Status Recruiting
Enrollment 22
Est. completion date December 30, 2023
Est. primary completion date November 1, 2023
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Women diagnosed with stage I to III breast/ovarian cancer aged 18 to 65 years. - Receiving chemotherapeutic agents containing taxanes and/or anthracyclines. - Willing to agree to shave thinning hair at baseline. - Willingness to be photographed and consent to photographic disclosure. - Able to understand and willing to sign an informed consent form. - Willing and able to follow all study instructions and attend all study visits. - Subjects taking thyroid replacement medication must be on stable doses for 6 months prior to enrollment and remain on the same maintenance dose throughout the study. - If female of childbearing age, must have a negative serum or urine pregnancy test at screnning (visit 0). Use a highly effective method of contraception during the study; do not plan a pregnancy for the duration of the study. Exclusion Criteria: - Use of any products or devices used to promote scalp hair growth (e.g., finasteride or minoxidil, L-tyrosine, cold caps). - Sensitivity or allergy to any ingredient in the Ecohair product. - Active skin disease on the scalp (such as psoriasis or seborrheic dermatitis) or history of skin disease on the scalp that, in the opinion of the investigator, may interfere with the efficacy or safety evaluations of the study. - Active scalp trauma or other condition affecting the scalp that, in the opinion of the investigator may interfere with the conduct of the study or evaluations. - The presence of a permanent or difficult to remove hairpiece or wig that, in the opinion of the investigator, will interfere with study evaluations if not removed at each visit. - Failure to be able to perform assigned clinical visits.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
hair lotion
ECOHAIR

Locations

Country Name City State
Argentina Instituto Roffo Caba Buenos Aires

Sponsors (1)

Lead Sponsor Collaborator
Instituto de Oncología Ángel H. Roffo

Country where clinical trial is conducted

Argentina, 

Outcome

Type Measure Description Time frame Safety issue
Primary Percentage of scalp surface area covered at 30 days. The primary efficacy assessment is hair count in the target area (in a 1 cm2
circular area) using trichoscopy imaging.
30 days
Primary Time to event, defined as the time from the start of treatment to achieve 100% total hair coverage of the scalp. baseline-30 days
Secondary Scalp hair density at 30 days. 30 days
Secondary Subject satisfaction questionnare. questionnaire is related to satisfaction with the outcome of the treatment (lotion). baseline-30 days
Secondary Incidence and severity of local skin reactions. severity according to the National Cancer Institute's (NCI) Common Terminology Criteria for Adverse Events, version 5.0 (CTCAE v5.0) baseline- 60 days
See also
  Status Clinical Trial Phase
Recruiting NCT04986579 - Scalp Cooling in MBC Phase 2
Recruiting NCT06215469 - Portable Scalp Cooling System (PSCS) to Prevent Hair Loss for Breast Cancer Patients (Cooler Heads) N/A
Not yet recruiting NCT05484973 - Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss N/A
Recruiting NCT02797223 - "Impact of Chemotherapy-induced Alopecia on the Quality of Life of Women With Breast Cancer" N/A
Recruiting NCT04036994 - PBMT for the Management of CIA ( HAIRLASER ) N/A
Completed NCT03712696 - Efficacy and Safety of DIGNICAP™ System N/A
Recruiting NCT05177289 - Photobiomodulation Therapy in the Prevention and Management of Chemotherapy-Induced Alopecia N/A
Recruiting NCT06011525 - Prevention of Alopecia in Patients With Localised Breast Cancer N/A
Recruiting NCT05397457 - Effect of Helmet Type, Home-use Low-level Light Therapy Device for Chemotherapy-induced Alopecia N/A
Withdrawn NCT05365243 - A Pilot Study to Evaluate the Use of the AMMA Portable Scalp Cooling System From Cooler Heads N/A